Drugs / Trivalent Inactivated Influenza Virus Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00461981 Comparator | May → Dec 2007 | — | MedImmune LLC | Completed | Mixed |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent Inactivated Influenza Virus Vaccine | “TIV, Trivalent Inactivated Influenza Virus Vaccine” NCT00461981 ↗ |
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00461981 ↗ |
| Modality | Vaccine | “Trivalent Inactivated Influenza Virus Vaccine” NCT00461981 ↗ |
| Route | Intramuscular | “0.25 mL will be administered intramuscularly” NCT00461981 ↗ |